Long-term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

We analyzed the outcomes of patients who survived disease-free for 1-year or more following second allogeneic hematopoietic cell transplantation (HCT) for relapsed acute leukemia or myelodysplastic syndromes between 1980 and 2009. A total of 1285 patients received a second allogeneic transplant foll...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biol Blood Marrow Transplant
Asıl Yazarlar: Duncan, Christine N., Majhail, Navneet S., Brazauskas, Ruta, Wang, Zhiwei, Cahn, Jean-Yves, Frangoul, Haydar A., Hayashi, Robert J., Hsu, Jack W., Kamble, Rammurti T., Kasow, Kimberly A., Khera, Nandita, Lazarus, Hillard M., Loren, Alison W., Marks, David I., Maziarz, Richard T., Mehta, Paulette, Myers, Kasiani C., Norkin, Maxim, Pidala, Joseph A., Porter, David L., Reddy, Vijay, Saber, Wael, Savani, Bipin N., Schouten, Harry C., Steinberg, Amir, Wall, Donna A., Warwick, Anne B., Wood, William A., Yu, Lolie C., Jacobsohn, David A., Sorror, Mohamed L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4272862/
https://ncbi.nlm.nih.gov/pubmed/25316109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.10.006
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller